Biden Proposes Coverage of Obesity Drugs in Medicare, Medicaid

(MedPage Today) -- Medicare and Medicaid recipients with obesity would have access to coverage of pricey GLP-1 receptor agonists like semaglutide (Wegovy) or tirzepatide (Zepbound) under a regulation proposed Tuesday by the Centers for Medicare...